Reservoir Neuroscience is an early-stage biotechnology company advancing a new class of therapy designed to restore the brain's protective barrier — opening a fundamentally new approach to neurological disease.
The blood-brain barrier is the brain's first line of defense — and when it fails, the consequences reach across nearly every neurological condition. Reservoir is building therapeutics that target the barrier itself, rather than working around it.
A therapeutic designed to repair the barrier's integrity — the first approach of its kind.
Targeting a pathway others have not, with the potential to apply broadly across CNS disease.
Early-stage discovery focused on a clear path toward the clinic.
Founded and led by a team committed to building a serious neuroscience company.
Co-founder & CEO
Co-founder
665 3rd Street, Suite 250, San Francisco, CA 94107
For partnerships, investors, and press inquiries.
665 3rd Street, Suite 250
San Francisco, CA 94107